Stockscreener 앱 받기
160.50
1.07%
-1.83
전일 마감가:
$162.33
열려 있는:
$161.31
하루 거래량:
82,896
Relative Volume:
0.10
시가총액:
$7.90B
수익:
$4.06B
순이익/손실:
$413.08M
주가수익비율:
20.04
EPS:
8.01
순현금흐름:
$560.48M
1주 성능:
-1.61%
1개월 성능:
-4.37%
6개월 성능:
-2.27%
1년 성능:
-16.26%
1일 변동 폭
$157.20
$161.62
1주일 범위
$157.20
$165.22
52주 변동 폭
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
명칭
Charles River Laboratories International Inc
전화
781-222-6000
주소
251 BALLARDVALE ST, WILMINGTON, MA
CRL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
160.47 | 7.94B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
479.67 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
194.98 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
631.17 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.67 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.03 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-23 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-05-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-05-08 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-03-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-03-03 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2025-01-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-01-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-18 | 다운그레이드 | CLSA | Hold → Underperform |
| 2024-11-07 | 업그레이드 | CLSA | Underperform → Hold |
| 2024-10-23 | 개시 | CLSA | Underperform |
| 2024-10-14 | 개시 | Redburn Atlantic | Sell |
| 2024-10-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-01 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 다운그레이드 | Argus | Buy → Hold |
| 2024-06-07 | 개시 | Mizuho | Neutral |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-09-13 | 개시 | TD Cowen | Market Perform |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-02-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-09-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-04 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | 개시 | Guggenheim | Neutral |
| 2022-04-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-07 | 개시 | Stephens | Overweight |
| 2022-02-17 | 재확인 | BofA Securities | Buy |
| 2022-02-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-02-17 | 재확인 | Deutsche Bank | Buy |
| 2022-02-17 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-17 | 재확인 | UBS | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-07-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-05-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-02-18 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-18 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | 개시 | SVB Leerink | Outperform |
| 2019-04-30 | 재개 | Evercore ISI | Outperform |
| 2018-12-14 | 개시 | Deutsche Bank | Buy |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-08-23 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Published on: 2025-09-03 20:26:19 - khodrobank.com
Using AI based signals to follow Charles River Laboratories International Inc.Portfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Charles River enhances cell therapy flex platform through collaboration with Akadeum Life Sciences - MarketScreener
Published on: 2025-09-03 08:57:14 - Newser
Published on: 2025-09-03 08:56:45 - Newser
What high frequency data says about Charles River Laboratories International Inc.Market Activity Summary & Risk Controlled Swing Trade Alerts - Newser
Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences - Yahoo Finance
Price momentum metrics for Charles River Laboratories International Inc. explainedMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
How sentiment analysis helps forecast Charles River Laboratories International Inc.Quarterly Portfolio Summary & Target Return Focused Picks - Newser
Combining price and volume data for Charles River Laboratories International Inc.July 2025 Gainers & Capital Protection Trading Alerts - Newser
Advanced analytics toolkit walkthrough for Charles River Laboratories International Inc.Bond Market & Real-Time Stock Price Movement Reports - Newser
Sentiment analysis tools applied to Charles River Laboratories International Inc.Portfolio Risk Report & Intraday High Probability Alerts - Newser
Leading vs lagging indicators on Charles River Laboratories International Inc. performanceWeekly Investment Report & Technical Confirmation Alerts - Newser
Measuring Charles River Laboratories International Inc.’s beta against major indicesEntry Point & Daily Oversold Bounce Ideas - Newser
Institutional scanner results for Charles River Laboratories International Inc.Recession Risk & Weekly Chart Analysis and Guides - Newser
Will Charles River Laboratories International Inc. stock go up soonEarnings Beat & Risk Controlled Stock Alerts - Newser
Chart overlay techniques for tracking Charles River Laboratories International Inc.July 2025 Final Week & Risk Managed Investment Signals - Newser
Published on: 2025-09-03 01:36:19 - Newser
Building trade automation scripts for Charles River Laboratories International Inc.Quarterly Market Review & Consistent Profit Trading Strategies - Newser
Regression analysis insights on Charles River Laboratories International Inc. performanceChart Signals & Reliable Price Action Trade Plans - Newser
How high can Charles River Laboratories International Inc. stock goProduct Launch & Accurate Buy Signal Alerts - Newser
Volatility clustering patterns for Charles River Laboratories International Inc.Wall Street Watch & Safe Swing Trade Setups - Newser
Developing predictive dashboards with Charles River Laboratories International Inc. data2025 Market Sentiment & Weekly High Return Opportunities - Newser
Is Charles River Laboratories International Inc. likely to announce a buybackPortfolio Gains Report & Smart Investment Allocation Insights - khodrobank.com
Applying Wyckoff theory to Charles River Laboratories International Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
AI-driven drug discovery picks up as FDA pushes to reduce animal testing - Reuters
Will Charles River Laboratories International Inc. benefit from geopolitical trendsWeekly Earnings Recap & Reliable Momentum Entry Alerts - khodrobank.com
Does Charles River Laboratories International Inc. stock have upside surprise potentialWeekly Profit Summary & Weekly Return Optimization Plans - khodrobank.com
Is Charles River Laboratories International Inc. forming a breakout patternJuly 2025 Volume & Community Consensus Trade Signals - khodrobank.com
Can a trend reversal in Charles River Laboratories International Inc. lead to recoveryMarket Movement Recap & Fast Entry Momentum Alerts - Newser
Is Charles River Laboratories International Inc. stock bottoming outQuarterly Market Review & Community Consensus Trade Signals - Newser
Tools to assess Charles River Laboratories International Inc.’s risk profileMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Real time scanner hits for Charles River Laboratories International Inc. explainedDividend Hike & Safe Capital Growth Tips - Newser
Using data filters to optimize entry into Charles River Laboratories International Inc.CEO Change & Stock Market Timing Techniques - Newser
Published on: 2025-09-02 00:42:17 - Newser
Charles River Laboratories International Inc. stock volume spike explainedTrade Entry Summary & Real-Time Buy Zone Alerts - Newser
What earnings revisions data tells us about BigBear.ai Holdings Inc. Equity WarrantTrade Entry Summary & High Conviction Buy Zone Picks - Newser
Stock Analysis | Charles River Laboratories International OutlookMixed Signals Amid Strong Fundamentals - AInvest
How to use a screener to detect Charles River Laboratories International Inc. breakoutsJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
How to track smart money flows in Charles River Laboratories International Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
What is Charles River Laboratories International Inc. s 5 year growth outlookRate Hike & Daily Market Momentum Tracking - khodrobank.com
Technical analysis overview for Charles River Laboratories International Inc. stock - Newser
Risk vs reward if holding onto Charles River Laboratories International Inc.Price Action & Reliable Entry Point Trade Alerts - Newser
Is Charles River Laboratories International Inc. meeting your algorithmic filter criteria2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - Newser
Charles River Stock May Benefit From Joining EASYGEN Consortium - sharewise.com
Recap Report: Is Charles River Laboratories International Inc. likely to announce a buybackJuly 2025 Recap & Accurate Technical Buy Alerts - khodrobank.com
Charles River Laboratories International Inc (CRL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
0.19%
자본화:
|
볼륨(24시간):